» Articles » PMID: 32451301

A Picture of the Covid-19 Impact on IVIRMA Fertility Treatment Clinics in Spain and Italy

Overview
Publisher Elsevier
Date 2020 May 27
PMID 32451301
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The emergence of the novel coronavirus infection that arose in Wuhan, China in December 2019 has resulted in an epidemic that has quickly expanded to become one of the most significant public health threats in recent times. Unfortunately, the disease has spread globally. On March 11th (2020) World Health Organization (WHO) declared Covid-19 a pandemic and has called governments to take urgent and aggressive action to change the course of the outbreak. Within the context of Assisted Reproduction, both reproductive medicine professionals and patients are also fighting against this unprecedented viral pandemic. In view of events, most of us had to make serious decisions, some of them with a lack of scientific evidence due to the circumstances and with the only objective of ensuring the safe care of our patients, reduce non-essential contacts and prevent possible maternal and fetal complications in future pregnancies. Pregnant women should not be considered at high risk for developing severe infection. Up to date, there are no reported deaths in pregnant women with Covid-19, while in the cases that have presented pneumonia because of Covid-19, the symptoms have been moderate and with a good prognosis in recovery.

Citing Articles

A multi-faceted exploration of unmet needs in the continuing improvement and development of fertility care amidst a pandemic.

Augustyniak M, Coticchio G, Esteves S, Kupka M, Hong C, Fincham A Int Braz J Urol. 2024; 50(5):631-650.

PMID: 39059016 PMC: 11446562. DOI: 10.1590/S1677-5538.IBJU.2024.9915.


The Multi-faceted Effects of COVID-19 on Female Reproductive Health: An Updated Narrative Review.

Al-Bdairi A, Makki H, Shawki O, Alkhudair S, Al-Hilli N, Alkhalidi B Cureus. 2024; 16(4):e57944.

PMID: 38738039 PMC: 11082527. DOI: 10.7759/cureus.57944.


Effects of COVID-19 Infection and Vaccination on the Female Reproductive System: A Narrative Review.

Pourmasumi S, Kounis N, Naderi M, Hosseinisadat R, Khoradmehr A, Fagheirelahee N Balkan Med J. 2023; 40(3):153-164.

PMID: 37114907 PMC: 10175880. DOI: 10.4274/balkanmedj.galenos.2023.2023-3-4.


COVID-19-related uncertainty: fertility staff experiences of its sources, processing, responses, and consequences.

Gameiro S, Armstrong K, Carluke N, Baccino G, Zegers-Hochschild F, Boivin J Hum Reprod. 2022; 38(2):247-255.

PMID: 36534892 PMC: 9890239. DOI: 10.1093/humrep/deac262.


The impact of COVID-19 mitigation measures on fertility patients and clinics around the world.

Cutting E, Catt S, Vollenhoven B, Mol B, Horta F Reprod Biomed Online. 2022; 44(4):755-763.

PMID: 35190253 PMC: 8712431. DOI: 10.1016/j.rbmo.2021.12.016.


References
1.
Qiao J . What are the risks of COVID-19 infection in pregnant women?. Lancet. 2020; 395(10226):760-762. PMC: 7158939. DOI: 10.1016/S0140-6736(20)30365-2. View

2.
Schwartz D, Graham A . Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections. Viruses. 2020; 12(2). PMC: 7077337. DOI: 10.3390/v12020194. View

3.
. The Novel Coronavirus Outbreak: What We Know and What We Don't. Cell. 2020; 180(6):1034-1036. PMC: 7154513. DOI: 10.1016/j.cell.2020.02.027. View

4.
Liang H, Acharya G . Novel corona virus disease (COVID-19) in pregnancy: What clinical recommendations to follow?. Acta Obstet Gynecol Scand. 2020; 99(4):439-442. DOI: 10.1111/aogs.13836. View

5.
Kimberlin D, Stagno S . Can SARS-CoV-2 Infection Be Acquired In Utero?: More Definitive Evidence Is Needed. JAMA. 2020; 323(18):1788-1789. DOI: 10.1001/jama.2020.4868. View